All In Biotech

Drug Trial Radar · NCT02365532

Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Adults

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effect of Oral GS-6615 on Dofetilide-Induced QT Prolongation, Safety, and Tolerability in Healthy Subjects

Last checked: Nov 20, 2026Latest source record: May 20, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

60

Actual

Start

Feb 2015

Primary completion

May 2015

Study completion May 2015

Sponsor

Lead sponsor
Gilead SciencesGilead Sciences (GILD)
Sponsor type
Industry
First posted
Feb 19, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This study will evaluate the effect of oral GS-6615 on QTc interval in healthy adults with dofetilide-induced QTc prolongation.

Conditions

  • Long QT Syndrome

Interventions

  • GS-6615Drug

    GS-6615 tablets administered orally

  • Placebo to match GS-6615Drug

    Placebo to match GS-6615 tablets administered orally

  • Placebo to match dofetilideDrug

    Placebo to match dofetilide capsules administered orally

  • DofetilideDrug

    Dofetilide 500 μg capsules administered orally according to the current prescribing information

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in daytime QT interval corrected for heart rate using the Fridericia formula (QTcF)Time frame: Up to 6 days
  2. Pharmacokinetic (PK) profiles of GS-6615 and dofetilideTime frame: Predose and postdose on Days -2 through Day 4

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Spaulding Clinical Research, LLC

    West Bend, Wisconsin

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.